JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION

Scope & Guideline

Advancing the Frontiers of Receptor Biology

Introduction

Welcome to the JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1079-9893
PublisherTAYLOR & FRANCIS LTD
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1980 to 1981, from 1983 to 2024
AbbreviationJ RECEPT SIG TRANSD / J. Recept. Signal Transduct.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND

Aims and Scopes

The JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION is dedicated to advancing the understanding of receptor biology and signaling pathways that underpin various physiological and pathological processes. The journal serves as a platform for researchers to disseminate their findings on the roles of receptors in health and disease, particularly focusing on novel therapeutic strategies and drug discovery.
  1. Receptor Pharmacology and Signaling Mechanisms:
    This area encompasses studies exploring the pharmacological properties of various receptors, including GPCRs and ion channels, and their downstream signaling pathways. The aim is to elucidate the molecular mechanisms involved in receptor activation and modulation.
  2. In Silico and Computational Approaches:
    The journal features research utilizing molecular docking, dynamics simulations, and QSAR modeling to predict interactions between receptors and potential therapeutic compounds, underscoring the importance of computational methods in drug discovery.
  3. Therapeutic Applications and Drug Discovery:
    Research focusing on the identification of novel receptor agonists and antagonists, particularly in the context of diseases such as cancer, diabetes, and neurodegenerative disorders, highlighting innovative therapeutic strategies.
  4. Pathophysiological Roles of Receptors:
    Investigations into the roles of receptors in various diseases, including cancer, cardiovascular disorders, and metabolic syndromes, emphasizing the clinical relevance of receptor biology.
  5. Cross-talk Between Signaling Pathways:
    Studies that explore interactions between different signaling pathways mediated by receptors, which can provide insights into complex regulatory mechanisms in cellular responses.
The JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION is witnessing a dynamic evolution in its thematic focus, as evidenced by the recent papers published. This section outlines the emerging trends and themes that are gaining traction within the journal, reflecting current research priorities and scientific advancements.
  1. Targeted Therapy and Precision Medicine:
    An increasing number of studies are focusing on targeted therapies that exploit specific receptor pathways for precision treatment in diseases like cancer, highlighting the shift towards personalized medicine.
  2. Role of Non-Coding RNAs in Receptor Signaling:
    Research on microRNAs and long non-coding RNAs that modulate receptor signaling pathways is gaining prominence, indicating a growing interest in the regulatory roles of these molecules in health and disease.
  3. In Vitro and In Vivo Models for Drug Testing:
    There is a notable trend towards utilizing advanced in vitro and in vivo models to study receptor functions and therapeutic interventions, enhancing the translational aspect of receptor research.
  4. Integrative Approaches Combining Multiple Modalities:
    Emerging studies are increasingly adopting integrative methodologies that combine computational, biochemical, and cellular techniques to provide comprehensive insights into receptor signaling and pharmacology.
  5. Impact of Environmental Factors on Receptor Function:
    Research exploring how environmental changes, such as hypoxia or oxidative stress, influence receptor activities and signaling pathways is becoming more prevalent, reflecting a broader understanding of receptor biology in physiological contexts.

Declining or Waning

While the JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION has consistently focused on key areas of receptor biology, certain themes appear to be diminishing in prominence within the recent publications. This section highlights those topics that have seen a reduced frequency or focus in the journal's output.
  1. Traditional Pharmacology of Known Receptors:
    Research that solely focuses on well-characterized receptors without exploring novel therapeutic implications or innovative methodologies is less frequently published. This shift indicates a move towards more complex and novel studies involving receptor interactions and signaling.
  2. Basic Mechanistic Studies without Clinical Relevance:
    There has been a noticeable decline in purely mechanistic studies that do not connect to clinical applications or therapeutic potential, reflecting a growing expectation for research to have direct implications for treatment or drug development.
  3. Exploration of Less Studied Receptors:
    Research on lesser-known or orphan receptors appears to be waning, as the journal increasingly prioritizes studies that focus on prominent receptors with established clinical relevance, potentially due to the demand for impactful findings.

Similar Journals

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Elevating discourse in biochemistry and biophysics.
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCEISSN: 0006-291XFrequency: 52 issues/year

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, published by Academic Press Inc Elsevier Science, stands as a leading periodical in the fields of biochemistry, biophysics, cell biology, and molecular biology. With an ISSN of 0006-291X and an E-ISSN of 1090-2104, this esteemed journal has been a pivotal platform for the dissemination of groundbreaking research since its inception in 1959, continuing to publish influential findings through at least 2024. It holds a commendable Q2 ranking in Biochemistry and Q1 status in Biophysics as of 2023, reflecting its high impact and relevance in the field, supported by its strong Scopus rankings—ranking #43 in Biophysics and maintaining a presence in the top quartiles of several related categories. Although it is not an open-access journal, it provides critical insights and essential data that cater to researchers, professionals, and students keen on advancing their understanding of complex biochemical and biophysical processes. Its significant contributions to the scientific community underscore the importance of this journal as a reference point for innovative research and collaborative discourse.

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Unraveling Cellular Energy Transformations and Membrane Mysteries
Publisher: SPRINGER/PLENUM PUBLISHERSISSN: 0145-479XFrequency: 6 issues/year

JOURNAL OF BIOENERGETICS AND BIOMEMBRANES, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal dedicated to the study of bioenergetics and biomembranes, covering essential topics such as cellular energy transformation and membrane dynamics. Since its inception in 1976, the journal has developed a robust reputation within the scientific community, currently holding a Q3 ranking in Cell Biology and a Q2 ranking in Physiology for 2023. Boasting a prestigious Scopus Rank in both Biochemistry and Physiology, it serves as a crucial platform for disseminating pioneering research findings. With its commitment to quality and innovation, the journal plays a significant role in advancing our understanding of the fundamental processes that underlie life at the cellular level. Although it does not offer open access options, the journal remains accessible through universities and research institutions, ensuring that vital research is widely shared among scholars, professionals, and students alike. The JOURNAL OF BIOENERGETICS AND BIOMEMBRANES is essential for anyone seeking to contribute to or stay informed about developments in this dynamic field.

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH

Charting New Territories in Drug Discovery
Publisher: TAYLOR & FRANCIS LTDISSN: 1028-6020Frequency: 12 issues/year

JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH is a prestigious publication in the field of natural products, focusing on valuable research spanning analytical chemistry, pharmacology, and complementary medicine. Published by Taylor & Francis Ltd in the United Kingdom, this journal has established itself as a key resource for academics and professionals seeking to explore advancements in drug discovery and organic chemistry. With a converged publication timeline from 1998 to 2024, the journal boasts several commendable category quartiles as of 2023, reflecting its robust standing in the research community: Q2 in Complementary and Alternative Medicine, Q3 in multiple domains including Analytical Chemistry and Organic Chemistry, and Q4 in Molecular Medicine. Although it currently does not offer open access, the journal remains a valuable compendium for empirical research and innovative studies in areas such as pharmacology and medicinal chemistry. Researchers, professionals, and students alike will find the JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH to be an essential platform for sharing groundbreaking findings and fostering collaborations that lead to significant advancements in science and health.

Biomolecules & Therapeutics

Innovating Drug Discovery through Rigorous Science
Publisher: KOREAN SOC APPLIED PHARMACOLOGYISSN: 1976-9148Frequency: 4 issues/year

Biomolecules & Therapeutics is a prominent journal published by the Korean Society of Applied Pharmacology, dedicated to advancing knowledge in the fields of Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. With an ISSN of 1976-9148 and an E-ISSN of 2005-4483, this journal serves as a vital platform for researchers and professionals to disseminate their findings from 2008 through 2024. Ranking in the Q2 category across multiple relevant fields, including Pharmacology and Drug Discovery, and consistently placing in the 60th to 70th percentiles in Scopus rankings, Biomolecules & Therapeutics exemplifies a commitment to high-quality research and scientific integrity. Although it operates on a traditional access model, readers can be assured of the journal's rigorous peer-review process, ensuring that published articles contribute meaningfully to ongoing discourse in pharmacological and biochemical research. Located in Seoul, South Korea, the journal stands at the forefront of innovation in healthcare, making it an essential resource for academics, students, and industry professionals alike.

MOLECULAR AND CELLULAR BIOCHEMISTRY

Elevating Knowledge in Biochemistry Since 1973
Publisher: SPRINGERISSN: 0300-8177Frequency: 12 issues/year

MOLECULAR AND CELLULAR BIOCHEMISTRY, an esteemed journal published by SPRINGER, serves as a prominent platform in the fields of biochemistry and molecular biology. With a history of dissemination since 1973, this journal has made significant contributions to the understanding of biochemical processes at the molecular level. The MOLECULAR AND CELLULAR BIOCHEMISTRY journal focuses on a myriad of topics including but not limited to cellular biochemistry, clinical biochemistry, and interdisciplinary approaches in medicine, boasting a commendable categorization in the 2023 Scopus ranks where it falls under Q3 in Cell Biology, Q2 in Clinical Biochemistry, Q1 in Medicine (miscellaneous), and Q2 in Molecular Biology. Although the journal is not open access, it provides access options through institutional subscriptions, making valuable research accessible to a wider audience. With its rigorous peer-review process and high impact within the scientific community, this journal aims to advance knowledge and stimulate exploration in biochemical research, making it essential reading for researchers, professionals, and students alike.

FREE RADICAL RESEARCH

Pioneering Research on Biological Free Radicals
Publisher: TAYLOR & FRANCIS LTDISSN: 1071-5762Frequency: 12 issues/year

FREE RADICAL RESEARCH, published by TAYLOR & FRANCIS LTD, stands at the forefront of studies in biochemistry and medicine, with a distinguished trajectory since its inception in 1985. This esteemed journal, which boasts an ISSN of 1071-5762 and an E-ISSN of 1029-2470, is recognized for its impactful contributions within the scientific community, as evidenced by its Q2 ranking in the 2023 category quartiles for both Biochemistry and miscellaneous Medicine. Utilizing rigorous peer-review standards, FREE RADICAL RESEARCH disseminates critical findings on the role of free radicals in biological systems, facilitating knowledge exchange among researchers, healthcare professionals, and students. Although it is not an open-access journal, its reach through academic databases ensures visibility and accessibility of groundbreaking research, making it an indispensable resource for those engaged in the dynamic fields of biochemistry and molecular biology. As the journal continues to evolve until 2024, it remains committed to advancing our understanding of oxidative stress and its implications for health and disease.

Current Molecular Pharmacology

Exploring Innovations in Drug Discovery
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1874-4672Frequency: 7 issues/year

Current Molecular Pharmacology, published by Bentham Science Publishers, is a prominent journal focused on the dynamic fields of pharmacology, drug discovery, and molecular medicine. With an ISSN of 1874-4672 and an E-ISSN of 1874-4702, this journal aims to disseminate cutting-edge research and review articles that showcase innovative methodologies and groundbreaking findings from 2008 through 2024. Holding a respectable Q3 category ranking in Drug Discovery, Molecular Medicine, and Pharmacology for 2023, Current Molecular Pharmacology serves as an essential platform for both established researchers and emerging scholars to share their insights. The journal is indexed in Scopus with its relevant ranks catering to pharmacology and molecular biology, ensuring it reaches a wide array of professionals, researchers, and students in the field. As a contributor to advancing pharmacological sciences, this journal provides invaluable access to the latest advancements and fosters ongoing dialogue in molecular pharmacology, positioning itself as a key resource in the exploration of therapeutic agents and their interactions.

International Journal of Biological Sciences

Championing Open Access in Life Science Research
Publisher: IVYSPRING INT PUBLISSN: 1449-2288Frequency: 10 issues/year

International Journal of Biological Sciences (ISSN: 1449-2288, E-ISSN: 1449-2288) is a premier open-access journal published by IVYSPRING INTERNATIONAL PUBLISHING since 2005, located in Australia. With a commitment to advancing knowledge in the life sciences, this journal covers a wide spectrum of disciplines, including Applied Microbiology and Biotechnology, Cell Biology, Developmental Biology, Ecology, Evolution, Behavior and Systematics, and Molecular Biology, earning a distinguished Q1 ranking in these fields as of 2023. It stands out with exceptional Scopus rankings, placing in the top ranks across multiple categories, such as the 98th percentile in Ecology, Evolution, Behavior and Systematics and the 94th percentile in Applied Microbiology and Biotechnology. The journal fosters an open access philosophy, ensuring that research findings are readily available to the scientific community and the public, and invites original research articles, reviews, and commentaries. With its mission to disseminate high-quality research, the International Journal of Biological Sciences serves as an essential resource for researchers, professionals, and students seeking to deepen their understanding and drive innovation in biological sciences.

BIOCHEMICAL JOURNAL

Connecting Ideas, Inspiring Discoveries in Biochemistry
Publisher: PORTLAND PRESS LTDISSN: 0264-6021Frequency: 24 issues/year

BIOCHEMICAL JOURNAL, published by Portland Press Ltd, stands as a leading publication in the fields of Biochemistry, Cell Biology, and Molecular Biology, reflecting a commitment to advancing scientific knowledge since its inception in 1945. With a distinguished Q1 ranking across these categories and impressive Scopus rankings, the journal serves as an invaluable resource for researchers, professionals, and students alike, facilitating critical discoveries and innovative research practices. Although not currently offering open access, the journal provides a platform for high-quality peer-reviewed articles, ensuring rigorous standards in the dissemination of biochemical research. Spanning over seven decades and continuing through to 2024, the BIOCHEMICAL JOURNAL fosters an environment where cutting-edge biochemical research thrives, supporting the global scientific community's efforts to address complex biological questions and enhance our understanding of fundamental cellular processes.

MOLECULAR AND CELLULAR PROBES

Unveiling Molecular Interactions for Tomorrow's Discoveries
Publisher: ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTDISSN: 0890-8508Frequency: 6 issues/year

MOLECULAR AND CELLULAR PROBES, published by Academic Press Ltd - Elsevier Science Ltd, stands as a prominent journal at the intersection of cell and molecular biology. With an ISSN of 0890-8508 and an E-ISSN of 1096-1194, this journal has consistently contributed to the scientific discourse since its inception in 1987, converging its scholarly content through to 2024. As a member of Q3 in both Cell Biology and Molecular Biology categories, it provides a platform for innovative research and critical insights into cellular mechanisms, signaling pathways, and molecular interactions. Its Scopus rankings position it within the top half of its categories, fostering a vibrant academic community that supports the exploration and advancement of biochemistry, genetics, and molecular biology. Although it does not currently offer Open Access, the high-quality peer-reviewed articles published in MOLECULAR AND CELLULAR PROBES are invaluable resources for researchers, professionals, and students who seek to stay at the forefront of breakthroughs in these essential fields.